A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017
Clinical trial NCT04927858 · COMPLETED
Trial details
- NCT number
- NCT04927858
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-02
- Primary completion
- 2018-11-15
- Enrollment
- 460558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.